ArticleOncotarget2015

MicroRNA-21 links epithelial-to-mesenchymal transition and inflammatory signals to confer resistance to neoadjuvant trastuzumab and chemotherapy in HER2-positive breast cancer patients.

Leticia De Mattos-Arruda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.